TWST.NASDAQTwist Bioscience CORP

Form 4: Twist Bioscience COO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Twist Bioscience CORP
🔒Login to Follow

Twist Bioscience's President and COO, Patrick John Finn, sold 2,755 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

  • Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), reported a transaction on November 3, 2025.
  • The transaction involved the disposition of 2,755 shares of common stock.
  • The shares were sold at a price of $32.0794 per share.
  • This sale was explicitly stated as a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
  • The transaction does not represent a discretionary trade by Mr. Finn.
  • Following this transaction, Mr. Finn beneficially owns 265,919 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' sale for tax withholding obligations related to vested Restricted Stock Units, indicating no change in management's discretionary sentiment towards the company.

Management Comments

  • The sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in insider sentiment or company fundamentals.

Key Dates

DateDescription
11/03/2025Date of transaction (sale of common stock)
11/05/2025Date the Form 4 was signed and filed

Recommendation

hold

This Form 4 reports a non-discretionary 'sell to cover' transaction by an insider to satisfy tax obligations upon RSU vesting. Such routine sales do not typically reflect a change in the insider's investment conviction or the company's fundamentals, thus warranting no change to an existing 'hold' recommendation.

Keywords

Twist Bioscience, TWST, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Patrick John Finn

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.